Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 6, 2006, Pages 471-476

  Guerrero Romero, Fernando ^a,b   Rodríguez Morán, Martha ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE   (Mexico)

Author keywords

C reactive protein; Hypomagnesemia; Inflammation; Malondialdehyde; Metabolic syndrome; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; MAGNESIUM; MALONALDEHYDE;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHRONIC INFLAMMATION; COLORIMETRY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPOMAGNESEMIA; INFLAMMATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SPECTROPHOTOMETRY; WAIST HIP RATIO;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; LOGISTIC MODELS; MAGNESIUM; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; MIDDLE AGED; OXIDATIVE STRESS; RISK;

EID: 33751182296     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.644     Document Type: Article

References (43)

1. Ferrannini E. Syndrome X. Horm Res 1993; 39(Suppl. 3): 107-111.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabetm Med 1998; 15: 539-553.
3. Schleicher E, Weigert C, Rohrbach H, Nerlich A, Bachmeier B, Friess U. Role of glucoxidation and lipid oxidation in the development of atherosclerosis. Ann NY Acad Sci 2005; 1043: 343-354.
4. Miller ER III, Appel LJ, Risby TH. Effect of dietary patterns on measures of lipid peroxidation, Results from a randomized clinical trial. Circulation 1998; 98: 2390-2395.
5. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
6. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-1292.
7. Binder CJ, Shaw PX, Chang MK, et al. The role of natural antibodies in atherogenesis. J Lipid Res 2005; 46: 1353-1363.
8. Itokawa Y. Magnesium intake and cardiovascular disease. Clin Calcium 2005; 15: 154-159.
9. Guerrero-Romero F, Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002; 39: 209-213.
10. Frölich M, Imhof A, Berg G, et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000; 23: 1835-1839.
11. Guerrero-Romero F, Rodríguez-Morán M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res 2005; 36: 250-257.
12. King DE, Mainous AG III, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr 2005; 24: 166-171.
13. Rodríguez-Morán M, Guerrero-Romero F. Elevated concentrations of TNF-alpha are related to low serum magnesium levels in obese subjects. Magnes Res 2004; 17: 189-196.
14. Guerrero-Romero F, Rodríguez-Morán M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord 2002; 26: 469-474.
15. Kramer JH, Mak IT, Phillips TM, Weglicki WB. Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med (Maywood) 2003; 228: 665-673.
16. Schiffrin EL, Touyz RM. Calcium, magnesium, and oxidative stress in hyperaldosteronism. Circulation 2005; 111: 830-831.
17. Ariza AC, Bobadilla N, Fernandez C, Munoz-Fuentes RM, Larrea F, Halhali A. Effects of magnesium sulfate on lipid peroxidation and blood pressure regulators in preeclampsia. Clin Biochem 2005; 38: 128-133.
18. Hasebe N. Oxidative stress and magnesium. Clin Calcium 2005; 15: 194-202.
19. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP): expert panel on detection, evaluation, and treatment of High Blood Cholesterol in Adults (Adult treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
20. Hutchinson W, Koenig W, Frölich M, Sund M, Lowe G, Pepys MB. Immunoradiometric assay of circulating C-Reactive protein: Age related values in the adult general population. Clin Chem 2000; 46: 934-938.
21. Macy EM, Hayes TE, Tracy RP. Variability in the measurements of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43: 52-58.
22. Rábago-Velasco M, Cortez-Valero H, Aguilar-Parada E, Arellano-Pérez H, Vázquez-Chávez C, Jiménez-Villaruel M. Malondial dehído plasmático en pacientes con diabetes mellitus tipo 2 y en pacientes con enfermedad coronaria. Gac Med Mex 2000; 136: 23-30.
23. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
24. Bonnefont D, Legrand A, Peynet J, Emerit J, Delattre J, Galli A. Distribution of thiobarbituric acid-reactive substances in lipoproteins and proteins in serum. Clin Chem 1989; 35: 2054-2058.
25. Soska V, Olsovsky J, Zechmeister A, Lojek A, Bouda J, García-Escamilla RM. Free oxygen radicals and lipoperoxides in type II (non-insulin-dependent) diabetic patients. Rev Mex Patol Clin 1997; 44: 62-66.
26. Yagi K. A simple fluorometric assay for liperoxide in blood plasma. Biochem Med 1976; 5: 212-216.
27. Barbagallo M, Dominguez LJ, Galioto A, et al. Role of magnesium in insulin action, diabetes, and cardio-metabolic syndrome X. Mol Aspects Med 2003; 24: 39-52.
28. Dong A, Caughey WS, Du Clos TW. Effects of calcium, magnesium, and phosphorylcholine on secondary structures of human C-reactive protein and serum amyloid P component observed by infrared spectroscopy. J Biol Chem 1994; 269: 6424-6430.
29. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005; 28: 1438-1444.
30. Hans CP, Chaudhary DP, Bansal DD. Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes Res 2003; 16: 13-19.
31. Hans CP, Chaudhary DP, Bansal DD. Magnesium deficiency increases oxidative stress in rats. Indian J Exp Biol 2002; 40: 1275-1279.
32. Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y. High fructose feeding of magnesium deficient rats is associated with increased plasma triglyceride concentration and increased oxidative stress. Magnes Res 2003; 16: 7-12.
33. Cernak I, Savic VJ, Kotur J, Prokic V, Veljovic M, Grbovic D. Characterization of plasma magnesium concentration and oxidative stress following graded traumatic brain injury in humans. J Neurotrauma 2000; 17: 53-68.
34. Cernak I, Savic V, Kotur J, et al. Alterations in magnesium and oxidative status during chronic emotional stress. Magnes Res 2000; 13: 29-36.
35. Seelig MS. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J Am Coll Nutr 1994; 13: 429-446.
36. Mak IT, Kramer JH, Weglicki WB. Suppression of neutrophil and endodethelial activation by substance P receptor blockade in the Mg-deficient rat. Magnes Res 2003; 16: 91-97.
37. Delgado AV, McManus AT, Chambers JP. Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 2003; 37: 355-361.
38. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complicat 2000, 14: 272-276.
39. Iskra M, Patelski J, Majewski W. Concentrations of calcium, magnesium, zinc and copper in relation to free fatty acids and cholesterol in serum of atherosclerotic men. J Trace Elem Electrolytes Health Dis 1993; 7: 185-188.
40. Kramer MS (ed.). Clinical Epidemiology and Biostatistics. A Primer for Clinical Investigators and Decision-Makers. Springer-Verlag: Berlin, Germany, 1988; 106.
41. Külpmann WR, Rössler J, Brunkhorst R, et al. Ionised and total magnesium serum concentrations in renal and hepatic diseases. Eur J Clin Chem Clin Biochem 1996; 34: 257-264.
42. Ryzen E, Servis KL, DeRusso P, Kershaw A, Stephen T, Rude RK. Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency. J Am Coll Nutr 1989; 8: 580-587.
43. Saha H, Harmoinen A, Karvonen AL, et al. Serum ionized versus total magnesium in patients with intestinal or liver disease. Clin Chem Lab Med 1998; 36: 715-718.